These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 6421240

  • 1. [Adjuvant chemotherapy for gastric cancer--relation between long-term administration of FT-207 and prognosis].
    Tanaka T, Inaba S, Naito K, Iguchi K, Yamagishi H, Kobayashi M.
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):130-7. PubMed ID: 6421240
    [Abstract] [Full Text] [Related]

  • 2. [Chemotherapy of gastric cancer patients with hepatic metastases].
    Tanaka T, Ishibashi H, Iguchi K, Hashimoto I.
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):232-6. PubMed ID: 6410993
    [Abstract] [Full Text] [Related]

  • 3. [Randomized study of long-term adjuvant chemotherapy with Futraful and mitomycin C in gastric cancer. A second study (fourth report)].
    Taguchi T, Usugane M, Inokuchi K, Hattori T, Inoue K, Kondo T, Akiyama H, Abe O, Nakajima T, Muto T.
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1833-9. PubMed ID: 3929692
    [Abstract] [Full Text] [Related]

  • 4. [Randomized study on the long-term adjuvant chemotherapy with ftorafur and mitomycin C for stomach cancer: second report].
    Abe O, Inokuchi K, Hattori T, Inoue K, Taguchi T, Kondo T, Akiyama H, Ito I, Nakajima T, Muto T.
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2408-17. PubMed ID: 6416184
    [Abstract] [Full Text] [Related]

  • 5. [Effect of postoperative long-term chemotherapy of stomach cancer using mitomycin C and futraful--the secondary study (1)].
    Kasai Y, Inokuchi K, Hattori T, Inoue K, Taguchi T, Kondo T, Akiyama H, Abe O, Ito I, Nakajima T, Muto T, Kikuchi K, Sugie S, Hayasaka A.
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1449-60. PubMed ID: 6820917
    [Abstract] [Full Text] [Related]

  • 6. [Evaluation of postoperative long-term chemotherapy using FT-207 for the stage III stomach cancer].
    Tanaka T, Nomi S, Naito K, Yamagishi H, Shibata J, Hashimoto I.
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1765-70. PubMed ID: 7184373
    [Abstract] [Full Text] [Related]

  • 7. [The optimal period for orally administered fluoropyrimidines as an adjuvant chemotherapy for gastric cancer--a pilot study using 5-FU tablets compared with surgical operation alone].
    Fujii M, Sakabe T, Wakabayashi K, Kochi M, Mochizuki F, Kasakura Y, Yamagata M, Noro M, Osawa T, Iwai S.
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1199-208. PubMed ID: 8031162
    [Abstract] [Full Text] [Related]

  • 8. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
    Nashimoto A, Nakajima T, Furukawa H, Kitamura M, Kinoshita T, Yamamura Y, Sasako M, Kunii Y, Motohashi H, Yamamoto S, Gastric Cancer Surgical Study Group, Japan Clinical Oncology Group.
    J Clin Oncol; 2003 Jun 15; 21(12):2282-7. PubMed ID: 12805327
    [Abstract] [Full Text] [Related]

  • 9. [Multihospital randomized study on adjuvant chemotherapy with mitomycin C and futraful or UFT in gastric cancer (Part 1). Comparison between futraful and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy)].
    Arima S, Simura H, Yamanouchi A, Fukuyama N, Hisatsugu T, Yamamoto H, Ohsato K, Ohkuma R, Nakamura Y, Abe R.
    Gan To Kagaku Ryoho; 1987 Aug 15; 14(8):2524-31. PubMed ID: 3113340
    [Abstract] [Full Text] [Related]

  • 10. [Multihospital randomized study on the adjuvant chemotherapy with mitomycin-C and Futraful for gastric cancer V. Estimation of 5-year survival rate].
    Kondo T, Inokuchi K, Hattori T, Inoue K, Taguchi T, Akiyama H, Abe O, Ito I, Nakajima T, Muto T, Kikuchi K, Kasai Y, Sugie S, Hayasaka A.
    Gan To Kagaku Ryoho; 1982 Nov 15; 9(11):2016-24. PubMed ID: 6820887
    [Abstract] [Full Text] [Related]

  • 11. [Comparative clinical study of adjuvant postoperative chemotherapy (5-FU, Tegafur, 5-FU + MMC) in curatively resected cases of gastric cancer. Study Group on 5-FU Oral Adjuvant Chemotherapy in Gastric Cancer].
    Nakajima T, Miwa K, Ohmori Y, Sakabe T, Fujii M, Kajitani T.
    Gan To Kagaku Ryoho; 1996 Aug 15; 23(9):1161-8. PubMed ID: 8751804
    [Abstract] [Full Text] [Related]

  • 12. [Multihospital randomized study on adjuvant chemotherapy with mitomycin C and futraful or UFT in gastric cancer--(Part 2). Comparisons between futraful and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy].
    Kuroda Y, Arima S, Ohsato K, Ohkuma R, Fukuyama N, Yamanouchi A, Hisatsugu T, Yamamoto H, Nakamura Y, Abe R.
    Gan To Kagaku Ryoho; 1989 Jun 15; 16(6):2235-40. PubMed ID: 2500069
    [Abstract] [Full Text] [Related]

  • 13. [A randomized study on the long-term adjuvant chemotherapy with ftorafur and mitomycin C for gastric cancer: the second study (III)].
    Muto T, Inokuchi K, Hattori T, Inoue K, Taguchi T, Kondo T, Akiyama H, Abe O, Nakajima T, Kikuchi K.
    Gan To Kagaku Ryoho; 1984 Sep 15; 11(9):1863-70. PubMed ID: 6433808
    [Abstract] [Full Text] [Related]

  • 14. [Randomized controlled trial of postoperative adjuvant chemotherapy with bestatin for gastric cancer].
    Tanaka T, Oka T, Hashimoto I.
    Gan To Kagaku Ryoho; 1985 Jan 15; 12(1):125-33. PubMed ID: 3917653
    [Abstract] [Full Text] [Related]

  • 15. [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-tegafur combination therapy with or without levamisole. 1].
    Niimoto M, Hattori T, Itoh I, Tamada R, Inokuchi K, Orita K, Furue H, Ogawa N, Toda T, Furusawa M, Koga S, Hashimoto I, Kondo T, Fujimoto S, Sugiyama Y, Abe O, Ohya M.
    Gan To Kagaku Ryoho; 1982 Dec 15; 9(12):2133-47. PubMed ID: 6820890
    [Abstract] [Full Text] [Related]

  • 16. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
    Hanazaki K, Mochizuki Y, Machida T, Yokoyama S, Sodeyama H, Sode Y, Wakabayashi M, Kawamura N, Miyazaki T.
    Hepatogastroenterology; 1999 Dec 15; 46(26):1238-43. PubMed ID: 10370699
    [Abstract] [Full Text] [Related]

  • 17. [Effect of adjuvant chemotherapy for patients with early gastric cancer].
    Sasaki A, Furusawa M, Tomoda H, Seo Y, Ohno S, Matsukuma A, Morita M, Kakeji Y.
    Gan To Kagaku Ryoho; 1994 Jan 15; 21(1):37-45. PubMed ID: 8291914
    [Abstract] [Full Text] [Related]

  • 18. [Effect of extended chemotherapy using tegafur following surgery of stage III stomach cancer].
    Machida T, Yoshida K, Ikeuchi H, Kano K, Takahashi M, Miura Y, Takahashi M.
    Gan To Kagaku Ryoho; 1983 Jun 15; 10(6):1461-5. PubMed ID: 6409004
    [Abstract] [Full Text] [Related]

  • 19. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
    Koo DH, Lee JL, Kim TW, Chang HM, Ryu MH, Yook JH, Oh ST, Kim BS, Lee JS, Kang YK.
    Eur J Surg Oncol; 2007 Sep 15; 33(7):843-8. PubMed ID: 17207959
    [Abstract] [Full Text] [Related]

  • 20. [An evaluation of perioperative and continuous infusion of tegafur as surgical adjuvant chemotherapy of resected gastric cancer].
    Tsugita M, Takasaki K, Yagawa A, Yamamoto M, Aruga A, Hayashi T, Shimizu Y, Kitamura Y, Suzuki H, Kobayashi S.
    Gan To Kagaku Ryoho; 1992 Mar 15; 19(3):333-7. PubMed ID: 1543359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.